Saturday 17 October 2026
Export PRTCY’s income statement to Excel — free account
PureTech Health PLC Sponsored ADR
PRTCY Healthcare Biotechnology
PureTech Health PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, down 3.50% from fiscal 2024.
14.56
0.34
−2.28%
Follow PRTCY
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Jan '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 6 | 3 | 5 | — | 3 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 36.93 | 35.29 | 20.92 | 20.92 |
Altman Z-Score |
0.83 | 1.47 | 1.97 | 3.40 | 35.57 | 1.90 | 25.21 | 27.77 | — | — |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
2.87 | 4.61 | 3.82 | 5.21 | 4.01 | 3.23 | 2.70 | 3.63 | 3.22 | 2.47 |
Beneish M-Score |
1.48 | (1.75) | (1.43) | 0.33 | — | (0.92) | — | (1.78) | — | — |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
(9.10) | (12.10) | (10.38) | (10.25) | (15.97) | (15.97) | (10.99) | (10.99) | (5.96) | (5.96) |
EV/EBITDA |
0.81 | 1.08 | 0.92 | 1.02 | 1.81 | 1.81 | 0.98 | 0.98 | 0.84 | 0.84 |
EV/Operating CF |
0.79 | 0.94 | 0.71 | 0.68 | 1.13 | 1.13 | 0.75 | 0.75 | 0.74 | 0.74 |
EV/FCF |
0.79 | 0.95 | 0.71 | 0.66 | 1.06 | 1.06 | 0.75 | 0.75 | 0.74 | 0.74 |
Quick Ratio |
6.41 | 9.19 | 6.64 | 3.84 | 3.87 | 2.16 | 2.10 | 2.25 | 2.26 | 1.18 |
Current Ratio |
6.59 | 9.33 | 6.76 | 3.99 | 3.99 | 2.22 | 2.22 | 2.29 | 2.29 | 1.21 |
Net Debt/EBITDA |
3.03 | 2.86 | 2.32 | 1.77 | 1.51 | 3.26 | 1.72 | 3.45 | 0.00 | 1.26 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 2.19% | 10.56% | 1.60% | 23.89% | 1.50% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.03 | 0.14 | 0.03 | 0.38 | 0.02 | 0.00 | 0.00 |
Asset Turnover |
0.01 | 0.01 | 0.00 | 0.02 | 0.00 | 0.02 | 0.00 | 0.01 | 0.00 | 0.01 |
Operating CF/Net income |
0.78 | (2.51) | 1.59 | 3.55 | 3.55 | 2.61 | 2.61 | (22.03) | (22.03) | (0.23) |
Capex/Depreciation |
0.08 | 0.07 | 0.13 | (0.24) | 0.00 | (0.77) | 0.00 | (0.82) | 0.00 | (1.88) |
Interest Coverage |
(2.24) | (16.89) | (14.39) | — | 0.00 | — | 0.00 | — | 0.00 | — |
| (30.76%) | 12.36% | (13.25%) | (8.90%) | 0.00% | (9.79%) | 0.00% | 0.92% | 0.00% | 89.35% | |
| (19.30%) | 8.25% | (9.54%) | (6.11%) | 0.00% | (6.26%) | 0.00% | 0.62% | 0.00% | 59.74% | |
ROIC |
(363.08%) | (290.85%) | (69.70%) | (58.07%) | 0.00% | (79.30%) | 0.00% | (28.25%) | 0.00% | (17.34%) |
Return on Tangible Assets |
(41.58%) | 15.20% | (21.82%) | (16.13%) | (15.06%) | (20.02%) | (18.66%) | 2.34% | 2.31% | 824.17% |
Average Days of Receivables |
636.93 | 115.06 | 1,547.91 | 522.49 | 535.04 | 170.09 | 172.71 | 91.16 | 85.51 | 86.61 |
Research and Development Expense of Revenue |
1,214.14% | 1,438.57% | 2,889.94% | 976.01% | 976.01% | 635.33% | 635.33% | 695.61% | 695.60% | 875.37% |
Selling, General and Administrative Expense of Revenue |
1,000.60% | 1,480.30% | 1,600.45% | 390.52% | 333.58% | 328.96% | 287.33% | 420.12% | 363.58% | 605.26% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
176.48% | 473.28% | 132.58% | 94.11% | 0.00% | 80.23% | 0.00% | 91.08% | 0.00% | 147.53% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1.29%) | (1.17%) | (0.86%) | (1.22%) | (0.62%) | (0.62%) | 2.71% | 2.83% | 4.78% | 4.78% |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.19 | 0.19 | 0.12 | 0.55 | 0.06 | 0.61 | 0.06 | 0.04 | 0.04 | 0.03 |
Operating CF per Share |
(3.54) | (5.28) | (3.83) | (6.28) | (0.69) | (5.52) | (0.55) | (0.46) | (0.47) | (0.35) |
Capex per Share |
0.01 | 0.01 | 0.02 | (0.08) | 0.00 | (0.20) | 0.00 | (0.02) | 0.00 | (0.04) |
Free Cash Flow per Share |
(3.52) | (5.27) | (3.81) | (6.36) | (0.69) | (5.72) | (0.55) | (0.48) | (0.47) | (0.39) |
Cash per Share |
11.99 | 14.88 | 11.84 | 12.29 | 1.39 | 16.78 | 1.65 | 1.41 | 1.37 | 0.57 |
Shareholders Equity per Share |
12.69 | 16.03 | 16.58 | 19.23 | 2.14 | 20.38 | 2.09 | 2.29 | 2.26 | 2.29 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
12.69 | 16.03 | 16.58 | 19.23 | 2.14 | 20.38 | 2.09 | 2.29 | 2.26 | 2.29 |
Free Cash Flow |
(84.87) | (134.12) | (105.30) | (180.97) | (196.15) | (163.90) | (157.65) | (137.25) | (135.26) | (110.69) |
Working Capital |
258.71 | 344.87 | 295.83 | 289.31 | 325.01 | 275.67 | 278.81 | 233.42 | 224.69 | 29.64 |
Capital Expenditures |
0.26 | 0.24 | 0.62 | (2.18) | (2.39) | (5.63) | (5.64) | (5.42) | (5.57) | (12.54) |
Net Current Asset Value |
75.98 | 191.55 | 111.46 | 231.14 | 259.66 | 139.95 | 141.54 | 77.89 | 74.98 | (121.93) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
(0.06) | (0.05) | (0.19) | 0.14 | 0.00 | 0.32 | 0.00 | 0.46 | 0.00 | 1.28 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.64 | 0.51 | 0.52 | 0.39 | 0.23 | 0.27 | 0.16 | 0.29 | 0.17 | 0.31 |
Cash ROIC |
(14.28%) | (17.05%) | (13.41%) | (19.82%) | (18.03%) | (15.18%) | (12.11%) | (12.80%) | 0.00% | (13.62%) |
Accounts Receivable Turnover |
0.97 | 0.62 | 0.18 | 1.03 | 0.00 | 3.15 | 0.00 | 4.47 | 0.00 | 5.25 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
4.83 | 7.82 | 18.24 | 15.23 | 16.61 | 5.52 | 5.57 | 2.63 | 2.58 | 1.87 |
Average Payables |
25.10 | 35.56 | 49.47 | 45.33 | 32.80 | 28.82 | 16.65 | 20.83 | 14.19 | 12.38 |
Average Assets |
568.67 | 648.30 | 698.31 | 824.33 | 867.68 | 968.00 | 973.38 | 965.59 | 947.06 | 704.96 |
Average Common Equity |
356.80 | 433.08 | 502.91 | 565.87 | 596.64 | 618.84 | 626.90 | 651.97 | 647.54 | 471.36 |
Columns are period end dates